TEE
ARRY

Tibra Equities Europe’s Array Biopharma Inc ARRY Stock Holding History

Tibra Equities Europe’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-26,164
Closed -$398K – 324
2018
Q3 		$398K Buy
+26,164
New +$401K 0.05% 163

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Tibra Equities Europe's ARRY Position: Q4 2018 in Review

Tibra Equities Europe sold out of Array Biopharma Inc (ARRY) in Q4 2018, closing a stake of 26,164 shares — an estimated $398K sold.

Tibra Equities Europe first reported a position in ARRY in Q3 2018 and held it in 1 quarter. The position peaked at $398K in Q3 2018. 236 funds tracked by Wall St. Rank hold ARRY as of Q4 2018.

  • Tibra Equities Europe reported no remaining Array Biopharma Inc position as of Q4 2018 after selling out during the quarter.
  • Tibra Equities Europe sold 26,164 Array Biopharma Inc shares in Q4 2018, an estimated $398K.
  • Tibra Equities Europe first reported a position in Array Biopharma Inc in Q3 2018 and held it in 1 quarter.
  • Tibra Equities Europe's Array Biopharma Inc position peaked at $398K in Q3 2018.
  • 236 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2018.

Based on Tibra Equities Europe's 13F filing for Q4 2018, filed 12 Feb 2019.